Qiagen’s outgoing chief executive Thierry Bernard, M.D., told investors the company does not “comment on rumors” as t...
Qiagen's outgoing CEO Thierry Bernard declined to comment as takeover talks and shareholder pressure swirl around the diagnostics specialist.
Why it mattersQiagen takeover chatter and Thierry Bernard's silence should prompt investors to reassess portfolio exposure to diagnostics acquisitions.